<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IP Patent News &#187; Announced</title>
	<atom:link href="http://www.ip-patent-news.com/tag/announced/feed" rel="self" type="application/rss+xml" />
	<link>http://www.ip-patent-news.com</link>
	<description>24/7 Technology,Internet,Bio Patent and Intellectual Property News &#38; Information Service</description>
	<lastBuildDate>Fri, 10 Sep 2010 04:56:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>TiaLinx, Inc. Announces Launch Of The Eagle45-W, Hands-Free Sense-Through-The-Wall Imager</title>
		<link>http://www.rfidsolutionsonline.com/article.mvc/TiaLinx-Inc-Announces-Launch-Of-The-0001?atc~c=771+s=773+r=001+l=a</link>
		<comments>http://www.ip-patent-news.com/tialinx-inc-announces-launch-of-the-eagle45-w-hands-free-sense-through-the-wall-imager#comments</comments>
		<pubDate>Tue, 07 Sep 2010 04:53:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Eaglew]]></category>
		<category><![CDATA[Launch]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/tialinx-inc-announces-launch-of-the-eagle45-w-hands-free-sense-through-the-wall-imager</guid>
		<description><![CDATA[[Story ID: 3581] TiaLinx, Inc., a developer of miniaturized mm-wave radars with integrated radio and antenna arrays, today announced the launch of the Eagle45-W, a hands-free precision Sense-Through-the-Wall Imager.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/tialinx-inc-announces-launch-of-the-eagle45-w-hands-free-sense-through-the-wall-imager">3581</a>]</small>
<p>TiaLinx, Inc., a developer of miniaturized mm-wave radars with integrated radio and antenna arrays, today announced the launch of the Eagle45-W, a hands-free precision Sense-Through-the-Wall Imager.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/tialinx-inc-announces-launch-of-the-eagle45-w-hands-free-sense-through-the-wall-imager/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The federal health IT push remains in the spotlight</title>
		<link>http://www.news-medical.net/news/20100813/The-federal-health-IT-push-remains-in-the-spotlight.aspx</link>
		<comments>http://www.ip-patent-news.com/the-federal-health-it-push-remains-in-the-spotlight#comments</comments>
		<pubDate>Fri, 13 Aug 2010 16:25:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Milestones]]></category>
		<category><![CDATA[Month]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/the-federal-health-it-push-remains-in-the-spotlight</guid>
		<description><![CDATA[[Story ID: 3399] Doctors across the country including Tahsina Atiquzzaman in Kissimmee, Fla., are &#8220;shredding paper charts and ushering in digital records as part of the health care milestones announced last month by the federal government,&#8221; The Orlando Sentinel/Modesto Bee reports.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/the-federal-health-it-push-remains-in-the-spotlight">3399</a>]</small>
<p>Doctors across the country including Tahsina Atiquzzaman in Kissimmee, Fla., are &#8220;shredding paper charts and ushering in digital records as part of the health care milestones announced last month by the federal government,&#8221; The Orlando Sentinel/Modesto Bee reports.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/the-federal-health-it-push-remains-in-the-spotlight/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Odyssey Healthcare second-quarter net patient service revenue increases 3.5% to $176.2 million</title>
		<link>http://www.news-medical.net/news/20100729/Odyssey-Healthcare-second-quarter-net-patient-service-revenue-increases-3525-to-241762-million.aspx</link>
		<comments>http://www.ip-patent-news.com/odyssey-healthcare-second-quarter-net-patient-service-revenue-increases-3-5-to-176-2-million#comments</comments>
		<pubDate>Thu, 29 Jul 2010 05:58:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Results]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/odyssey-healthcare-second-quarter-net-patient-service-revenue-increases-3-5-to-176-2-million</guid>
		<description><![CDATA[[Story ID: 3324] Odyssey HealthCare, Inc., one of the largest providers of hospice care in the United States, today announced financial results for the three and six months ended June 30, 2010.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/odyssey-healthcare-second-quarter-net-patient-service-revenue-increases-3-5-to-176-2-million">3324</a>]</small>
<p>Odyssey HealthCare, Inc., one of the largest providers of hospice care in the United States, today announced financial results for the three and six months ended June 30, 2010.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/odyssey-healthcare-second-quarter-net-patient-service-revenue-increases-3-5-to-176-2-million/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HealthStream second-quarter revenues increase 14% to $16.7M</title>
		<link>http://www.news-medical.net/news/20100727/HealthStream-second-quarter-revenues-increase-1425-to-24167M.aspx</link>
		<comments>http://www.ip-patent-news.com/healthstream-second-quarter-revenues-increase-14-to-16-7m#comments</comments>
		<pubDate>Tue, 27 Jul 2010 05:43:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Results]]></category>
		<category><![CDATA[Today]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/healthstream-second-quarter-revenues-increase-14-to-16-7m</guid>
		<description><![CDATA[[Story ID: 3261] HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, announced today results for the second quarter ended June 30, 2010.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/healthstream-second-quarter-revenues-increase-14-to-16-7m">3261</a>]</small>
<p>HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, announced today results for the second quarter ended June 30, 2010.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/healthstream-second-quarter-revenues-increase-14-to-16-7m/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Endologix second-quarter total revenue increases 19% to $15.7 million</title>
		<link>http://www.news-medical.net/news/20100723/Endologix-second-quarter-total-revenue-increases-1925-to-24157-million.aspx</link>
		<comments>http://www.ip-patent-news.com/endologix-second-quarter-total-revenue-increases-19-to-15-7-million#comments</comments>
		<pubDate>Fri, 23 Jul 2010 04:54:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Results]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/endologix-second-quarter-total-revenue-increases-19-to-15-7-million</guid>
		<description><![CDATA[[Story ID: 3149] Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2010.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/endologix-second-quarter-total-revenue-increases-19-to-15-7-million">3149</a>]</small>
<p>Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2010.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/endologix-second-quarter-total-revenue-increases-19-to-15-7-million/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hospitals hope to improve outlook by turning for-profit</title>
		<link>http://www.news-medical.net/news/20100714/Hospitals-hope-to-improve-outlook-by-turning-for-profit.aspx</link>
		<comments>http://www.ip-patent-news.com/hospitals-hope-to-improve-outlook-by-turning-for-profit#comments</comments>
		<pubDate>Wed, 14 Jul 2010 05:14:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[March]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Poor]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/hospitals-hope-to-improve-outlook-by-turning-for-profit</guid>
		<description><![CDATA[[Story ID: 2854] &#8220;For decades, the Detroit Medical Center and its network of eight hospitals have served as a safety net for thousands of poor patients throughout southeastern Michigan. So when its pending sale to a for-profit hospital system was announced in March, pediatrician James Collins began worrying whether the poor would still get the [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/hospitals-hope-to-improve-outlook-by-turning-for-profit">2854</a>]</small>
<p>&#8220;For decades, the Detroit Medical Center and its network of eight hospitals have served as a safety net for thousands of poor patients throughout southeastern Michigan. So when its pending sale to a for-profit hospital system was announced in March, pediatrician James Collins began worrying whether the poor would still get the care they need&#8221; (Gold, 7/13).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/hospitals-hope-to-improve-outlook-by-turning-for-profit/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Covidien acquires ev3 for $2.6 billion</title>
		<link>http://www.news-medical.net/news/20100713/Covidien-acquires-ev3-for-2426-billion.aspx</link>
		<comments>http://www.ip-patent-news.com/covidien-acquires-ev3-for-2-6-billion#comments</comments>
		<pubDate>Tue, 13 Jul 2010 04:58:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Approximately]]></category>
		<category><![CDATA[Consideration]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/covidien-acquires-ev3-for-2-6-billion</guid>
		<description><![CDATA[[Story ID: 2789] Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of ev3 Inc. for an aggregate consideration of approximately $2.6 billion, net of cash and short-term investments acquired.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/covidien-acquires-ev3-for-2-6-billion">2789</a>]</small>
<p>Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of ev3 Inc. for an aggregate consideration of approximately $2.6 billion, net of cash and short-term investments acquired.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/covidien-acquires-ev3-for-2-6-billion/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Broadcom Extends Offer Period for Innovision Research &amp; Technology PLC</title>
		<link>http://www.redorbit.com/news/technology/1890100/broadcom_extends_offer_period_for_innovision_research__technology_plc/index.html?source=r_technology</link>
		<comments>http://www.ip-patent-news.com/broadcom-extends-offer-period-for-innovision-research-technology-plc#comments</comments>
		<pubDate>Mon, 12 Jul 2010 11:07:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Broadcom]]></category>
		<category><![CDATA[Offer]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/broadcom-extends-offer-period-for-innovision-research-technology-plc</guid>
		<description><![CDATA[[Story ID: 2784] IRVINE, Calif., July 12 /PRNewswire-FirstCall/ &#8212; Broadcom Corporation (Nasdaq: BRCM), a global leader in semiconductors for wired and wireless communications, today announced its subsidiary, Broadcom International Ltd., has extended the offer period for its previously announced all-cash offer for Innovision Research &#038; Technology PLC, (a company listed on the Alternative Investment Market [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/broadcom-extends-offer-period-for-innovision-research-technology-plc">2784</a>]</small>
<p>IRVINE, Calif., July 12 /PRNewswire-FirstCall/ &#8212; Broadcom Corporation (Nasdaq: BRCM), a global leader in semiconductors for wired and wireless communications, today announced its subsidiary, Broadcom International Ltd., has extended the offer period for its previously announced all-cash offer for Innovision Research &#038; Technology PLC, (a company listed on the Alternative Investment Market of &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/broadcom-extends-offer-period-for-innovision-research-technology-plc/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adimab announces initiation of research collaboration with Novartis</title>
		<link>http://www.news-medical.net/news/20100709/Adimab-announces-initiation-of-research-collaboration-with-Novartis.aspx</link>
		<comments>http://www.ip-patent-news.com/adimab-announces-initiation-of-research-collaboration-with-novartis#comments</comments>
		<pubDate>Fri, 09 Jul 2010 15:52:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Adimab]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Today]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/adimab-announces-initiation-of-research-collaboration-with-novartis</guid>
		<description><![CDATA[[Story ID: 2760] Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of a research collaboration with Novartis (Basel, Switzerland). This agreement represents the fifth major partnership Adimab has announced since launching its platform at BIO 2009 in Atlanta, just one year ago. In addition, Adimab today announced the [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/adimab-announces-initiation-of-research-collaboration-with-novartis">2760</a>]</small>
<p>Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of a research collaboration with Novartis (Basel, Switzerland). This agreement represents the fifth major partnership Adimab has announced since launching its platform at BIO 2009 in Atlanta, just one year ago. In addition, Adimab today announced the receipt of a second milestone payment from its ongoing collaboration with Merck and Co.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/adimab-announces-initiation-of-research-collaboration-with-novartis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FUISZ Announces Advances in Devices and Solid Dosage Form</title>
		<link>http://www.redorbit.com/news/health/1887048/fuisz_announces_advances_in_devices_and_solid_dosage_form/index.html?source=r_health</link>
		<comments>http://www.ip-patent-news.com/fuisz-announces-advances-in-devices-and-solid-dosage-form#comments</comments>
		<pubDate>Thu, 01 Jul 2010 15:14:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Announced]]></category>
		<category><![CDATA[Fuisz]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/fuisz-announces-advances-in-devices-and-solid-dosage-form</guid>
		<description><![CDATA[[Story ID: 2594] MIAMI, July 1 /PRNewswire/ &#8212; FUISZ today announced two medical technology advances. First, FUISZ announced that it has received a notice of issuance from the United States Patent and Trademark Office for patent claims that cover a direct connection between prescribing physicians and blood analysis devices. The invention allows for the health [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/fuisz-announces-advances-in-devices-and-solid-dosage-form">2594</a>]</small>
<p>MIAMI, July 1 /PRNewswire/ &#8212; FUISZ today announced two medical technology advances. First, FUISZ announced that it has received a notice of issuance from the United States Patent and Trademark Office for patent claims that cover a direct connection between prescribing physicians and blood analysis devices. The invention allows for the health care provider to set the parameters of allowable &#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/fuisz-announces-advances-in-devices-and-solid-dosage-form/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
